Skip to main content
. Author manuscript; available in PMC: 2015 Jun 30.
Published in final edited form as: Vasc Endovascular Surg. 2012 Jun 11;46(6):447–454. doi: 10.1177/1538574412449911

Table 3.

Kidney Function

EPD Group, N (%) Control Group, N (%)
Improved 7 (16) 4 (22)
Unchanged 11 (68) 13 (72)
Decreased 0 (0) 1 (6)
Baseline Follow-up Baseline Follow-up
Serum creatinine (mg/dL) 2.15 ± 0.72 1.99 ± 0.58 2.15 ± 0.64 2.11 ± 0.98
eGFR (mL/min) 34.8 ± 13.6 36.0 ± 13 33.6 ± 12.8 35.8 ± 13.7
KDOQI class 2 0 0 1 2
  3A 5 5 3 2
  3B 6 8 8 6
  4 7 4 7 6
  5 1 0 0 0
Hemodialysis NA 2 NA 3
Deaths NA 5 NA 5

Abbreviations: EPD, embolic protection device; KDOQI, Kidney Disease Outcome and Quality Initiative; NA, not applicable.